Oramed Pharmaceuticals (ORMP) Interest Coverage Ratio (QoQ) (2011 - 2026)
Oramed Pharmaceuticals (ORMP) Interest Coverage Ratio (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.78% |
| Dec 31, 2025 | -154.60% |
| Sep 30, 2025 | 2.49% |
| Jun 30, 2025 | 95.87% |
| Mar 31, 2025 | -7,460.22% |
| Dec 31, 2024 | 188.08% |
| Sep 30, 2024 | 42.21% |
| Jun 30, 2024 | -140.07% |
| Mar 31, 2024 | -132.52% |
| Dec 31, 2023 | 539.27% |
| Sep 30, 2023 | 29.88% |
| Jun 30, 2023 | 99.04% |
| Mar 31, 2023 | -267.59% |
| Dec 31, 2022 | -1,545.33% |
| Sep 30, 2022 | 21.86% |
| Jun 30, 2022 | 7.54% |
| Nov 30, 2019 | -2,038.97% |
| Aug 31, 2019 | 98.05% |
| May 31, 2019 | -55.11% |
| Feb 28, 2019 | 67.62% |